The market is projected to expand at a compound annual growth rate of 6% from 2024 to 2034. Growing clinical evidence is beginning draw attention to the minimally invasive neurosurgical devices market ...

Siemens has announced plans to ‘deconsolidate’ its remaining stake in Siemens Healthineers by transferring 30% of shares to Simens shareholders. The company, whose stake had stood at 67%, will hand ...

Biogen has completed the acquisition of Alcyone Therapeutics, for $85m upfront payment, to boost central nervous system (CNS) drug delivery.

Zimmer Biomet has received 510(k) clearance from the US Food and Drug Administration (FDA) for ROSA Knee with OptimiZe technology.

Boston Scientific has entered an agreement with Siemens Healthineers to push forward commercialisation activities for the latter’s AcuNav 4D ICE catheter.

Clairity has concluded a $43m funding round, allowing it to advance commercialisation for its AI-powered breast cancer prediction platform.

The US FDA has granted 510(k) clearance, expanding the label of BrainsWay’s Deep Transcranial Magnetic Stimulation (TMS) system.

Beacon Biosignals has secured $86m in a Series B funding round aimed at expanding its neurodiagnostic dataset and furthering the clinical use of AI-driven brain health biomarkers.

From e-health records to a biotech hub in Tartu, Estonia is harnessing data, digital infrastructure, and investment to drive life sciences growth.

Minze Health has reached an agreement with Medtronic for three years to market the automated bladder diary solution, Minze Diary Pod.

ViTAA Medical’s aortic surgery planning tool has gained clearance from the US Food and Drug Administration (FDA), representing the first milestone in the company’s aim to bring a full spectrum aortic ...